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Investigative surgery 
Antibody localization 
antilymphocyte sera 
tn horse, rabbit, and goat 
D ming the 1a" 3 Y"=, th'" ha, been 
an increasing clinical use of heterologous 
antilymphocyte sera (ALS) or various glob-
ulin fractions (ALG) of these antisera.4 ,15, 
17-19, 21, 22 The most commonly used serum 
donor has been the horse. Numerous ef-
forts have been made to refine the globulin 
removed from the raw serum for eventual 
injection so that the ratio of desired equine 
antibodies to irrelevant protein would be 
increased. These attempts at purification 
were based upon evidence from many 
sources that the immunosuppressive activity 
of ALS is heavily concentrated in IgG or 
7S gamma globulin.6 , 8, g, 23 
In our own institution, a highly purified 
horse IgG (ALGG) was given a clinical 
trial in early 1968 with extremely disap-
pointing results. The ALGG, which was ad-
ministered in combination with azathioprine 
and prednisone, appeared to have a reduced 
ability to mitigate the rejection of renal 
homografts.l1, 19 A similar loss of efficacy of 
refined horse ALGG was noted by Clunie 
and associates3 in canine experiments. 
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As a consequence of these findings, the 
present study was undertaken to re-evaluate 
the location of various antibodies as well as 
the immunosuppressive effect in horse ALS. 
In addition, the same information about 
antibody localization \vas sought for ALS 
raised in rabbits and goats. 
METHODS 
Immunization. The immune serum ob-
tained from the three different animals was 
initially treated in the same way. It was 
sterilized by millipore filtration, inactivated 
by heating at 56° C. for 30 minutes, and 
then stored at 4° C. until testing. However, 
there were some differences in the details 
of the prior immunization. 
Horse. One horse received subcutaneous 
injections of 2.5 to 5 x 1010 canine splenic 
lymphocytes approximately once a week for 
9 weeks before bleeding. Two other ani-
mals were immunized with human spleen 
lymphocytes for 6 and 9 weeks, respectively, 
following the same schedule. 
Rabbit. Six New Zealand white rabbits 
were injected intraperitoneaIly once a week 
for 4 weeks with an average of 5 x 109 
human spleen lymphocytes per injection. 
One week after the last immunizing dose, 
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they were bled by heart puncture. The sera 
from the six rabbits were pooled for analy-
sis. 
Goat. Before being bled, one goat was im-
munized for 12 weeks by the same technique 
as that described for the horse except that 
the individual cell doses were 1 x 1010• 
Analysis of proteins. The proteins were 
separated by DEAE-cellulose column chro-
matography. Five to 6 m!. of raw ALS were 
brought to pH 8.0 by dialyzing against 
O.OlM sodiwn phosphate; the sera were 
then applied to a 2 by 20 cm. column con-
taining 20 Gm. of activated DEAE-cellu-
lose* that had been prebuffed to pH 8.0 
with O.OIM sodium phosphate and packed 
under 10 pounds of pressure. The samples 
were followed through the column by 
gradient elution with a solution of sodium 
phosphate that began at pH 8.0 (O.OIM) 
and finished after 900 m!. with pH 4.5 
(0.3M). The flow rate through the column 
was about I m!. per minute; 5 ml. were col-
lected in each test tube. The optical den-
sities of the eluates were measured spectro-
photometrically at 280 mIL. The collecting 
tubes contammg protein "peaks" were 
pooled and designated fractions I to VII 
(horse and rabbit) and I to VI (goat); 
for subsequent analyses these fractions were 
lyophilized and reconstituted at 50 times 
their original concentration. 
The total protein concentrations of the 
raw sera and the various fractions were de-
termined by the biuret method of Henry 
and co-workers.7 The presence and quantity 
of IgG in any of the fractions was detected 
by the agar immunodiffusion techniquet of 
Fahey and McKelvey.5 In addition, protein 
constituents were identified with cellulose 
acetate membrane electrophoresist and by 
microimmunoelectrophoresis§ with com-
mercial antisera. II 
*Whatman DE32, H. Reede Angel Inc., London, Eng-
land. 
tThe antirabbit IgG and antigoat IgG were obtained 
from Hyland Laboratories, Los Angeles, Calif. The anti-
horse IIlG was raised in rabbits with pure horse IgG. 
*Beckman Instruments, Inc., Fullerton, Calif. 
§LKB-Producter AB, Stockholm, Sweden. 
IIHyland Laboratories, Los Angeles, Calif. 
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Lymphocytotoxicity, leukoagglutination, 
hemagglutination, and thromboagglutina-
tion activities of the sera and the protein 
fractions were determined as described pre-
viously/o except for one modification in the 
thromboagglutinin titration. The incubation 
period for the thromboagglutination was for 
6 hours without agitation, instead of for 20 
minutes with agitation. 
Ammonium sulfate fractionation. 
Rabbit and goat ALS. Twenty milliliters 
of each of the two raw antisera were pre-
cipitated with 33, 36, and 40 percent satu-
rated ammonium sulfate (SAS). After re-
constituting the sediment to 20 m!. with 
normal saline, a second precipitation was 
carried out with the same concentration of 
SAS as before. The final sediment was then 
reconstituted to 10 m!. and dialyzed against 
normal saline before being submitted to 
analysis by the techniques described in the 
preceding section. 
Horse ALS. The differential ammonium 
sulfate fractionation of Allen and associates1 
was used to obtain two kinds of horse pro-
tein that were rich, respectively, in gamma 
globulin and T -equine (also known as gam-
mal or beta2) globulin. Sixty milliliters of 
horse ALS were added to the same volume 
of normal saline and precipitated with 33 
percent SAS. The sediment was reconsti-
tuted to 60 m!. with normal saline and again 
precipitated with 33 percent SAS. The 
final precipitate was reconstituted with 
normal saline to one third the original 
serum volume and dialyzed against nor-
mal saline. The product was designated as 
Fraction G. 
The supernatant from the first 33 percent 
SAS precipitation step was precipitated with 
50 percent SAS. The precipitate obtained 
was reconstituted to 60 m!. with normal 
saline, and a second 33 percent SAS pre-
cipitation was performed. This sediment was 
discarded, and the supernatant was again 
precipitated with 50 percent SAS. The last 
precipitate was reconstituted to one third 
the volume of the original serum and 
dialyzed against normal saline. The end 
product was designated as Fraction T. 
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Fig. 1. Analysis of the location of antibodies in the serum of a horse that had been immunized 
for 6 weeks with weekly subcutaneous injections of human splenic cells_ Adjuvant was not used 
in this or any of the other heterologous serum donors. The multiple analytic techniques shown 
were used to determine the varieties, concentrations, and activities of the proteins in the differ-
ent fractions. Alb = albumin; a, = alpha, globulin; a, = alpha. globulin; a,M = alpha. 
macroglobulin; f3, = beta, globulin; fl. = beta, globulin or T-equine; "Y = gamma globulin; 
IgA = immunoglobulin A; IgO = immunoglobulin G; IgM = immunoglobulin M; Tr = 
Transferrin. 
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In vivo testing. Serum was obtained from 
the horse that had been immunized for 9 
weeks against canine splenic lymphocytes; 
preliminary absorption was carried out with 
dog erythrocytes, thrombocytes, and plasma. 
The above described Fractions G and T were 
then prepared and either diluted or con-
centrated so that the gamma globulin and 
T-equine concentrations, respectively, were 
equal to those in the original absorbed se-
rum. They were then tested for their ability, 
when given subcutaneously, to induce 
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Fig. 2. The localization of antibodies in the pooled sera of six rabbits that had been immunized 
weekly for 4 weeks with human spleen cells subcutaneously. The protein constituents for 
which abbreviations were not given in Fig. 1 are Cp = ceruloplasmin and Hp = haptoglobin. 
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lymphopenia and to mItIgate rejection of 
renal homografts. The results were com-
pared with those obtained with the use of 
the absorbed ALS from which the fractions 
were obtained. Another group of control ani-
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mals was untreated. All recIpIent dogs in 
the three test series were injected daily with 
0.5 m!. per kilogram of the appropriate 
material, beginning 1 day before transplan-
tation and continuing until the day of death. 
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Fig. 3. The antibodies in goat ALS raised with human splenic cells over a period of 12 weeks. 
The only abbreviation not used in Figs. 1 and 2 is a,A = alpha, A globulin. 
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Table I. The protein concentrations and titers of crude globulin obtained by double 
precipitation with different proportions of saturated ammonium sulfate (SAS) * 
Protein concentration Antibodies 
Volume (Gm.%) 
Leukoagglutinin I 
Lympho-
(ml.) Total I Gamma cytotoxin 
RabbIt ALS 20.0 7.3 3.2 1 :1,024 1 :4,096 
33% SAS 10.5 2.2 1.9 1 :1,024 1:2,048 
36% SAS 11.8 2.5 2.0 1:1,024 1:4,096 
40% SAS 11.7 2.6 1.9 1:1,024 1:4,096 
Goat ALS 20.0 7.7 3.6 1 :512 1 :2,048 
33% SAS 11.5 4.9 4.4 1:512 1:1,024 
36% SAS 12.5 5.4 4.7 1:512 1 :1,024 
40% SAS 13.2 5.4 4.5 1 :512 1 :2,048 
*The gamma contribution to the total protein was calculated from electrophoresis scans. 
The peripheral lymphocytes were fre-
quently counted. 
RESULTS 
Chromatography and antibody localiza-
tion. 
Horse ALS. The results were essentially 
the same in the two horses that were given 
human splenic tissue as well as in the horse 
immunized with canine spleen. There were 
seven protein peaks. The lymphocytotoxic 
activity was very heavily, if not exclusively, 
concentrated in the IgG (Fig. 1). This was 
particularly evident in the pooled Fractions 
I and II in which only IgG was represented. 
The lymphocytotoxins in the Fractions III 
and IV were probably also contained in the 
IgG which contributed to these heteroge-
nous collections. 
In contrast, more than 80 percent of the 
leukoagglutinins were in the Fractions III 
and IV which consisted predominantly of 
IgA (also known as "fast" gamma G, or 
IgG(T). The hemagglutinins and thrombo-
agglutinins were mostly in the same loca-
tion, although these antibodies were also de-
tectable in the IgG (Fig. 1). 
Rabbit ALS. This antiserum was also sep-
arable into seven fractions. However, almost 
all the measured antibodies were in the IgG 
(Fig. 2). The only significant spread was of 
the hemagglutinins which were found in the 
IgM as well (Fig. 2) . 
Goat ALS. This goat ALS was separable 
into six fractions (Fig. 3). The distribution 
was very similar to that in the rabbit excep1. 
that the hemagglutinins were almost exclu-
sively in the IgM. The other antibodies were 
in the IgG. 
Ammonium sulfate fractions. 
Rabbit and goat ALS. The properties of 
the crude globulin obtained in both species 
by double precipitation with 33, 36, or 40 
percent SAS are shown in Table I and Fig. 
4. With 40 percent SAS, the antiwhite cell 
titers were fully retained. At 33 percent 
SAS, there was some loss of lymphocytotox-
icity, but the precipitated protein was much 
less heterogeneous. 
Horse ALS. The properties of the Frac-
tions G and T removed by differential am-
monium sulfate precipitation were essen-
tially the same with the use of the serum of 
the two horses immunized with human 
splenic lymphocytes and with the use of the 
serum of the third animal which was given 
canine spleen. Fraction G had a very high 
proportion of IgG compared with the T-
equine content. The Fraction T also con-
tained IgG (Fig. 5), but the predominant 
immunoglobulin was IgA. Before testing 
Fraction G for its immunosuppressive ef-
fect (see below), it was diluted to give the 
same gamma globulin content as in the ALS. 
A similar adjustment was made for the T-
equine content of Fraction T. The protein 
concentrations and the antibody activities of 
the adjusted fractions are shown in Table 
II. 
In vivo testing. Both the absorbed horse 
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Fig. 5. Electrophoresis and immunoelectrophoresis 
of the globulin fractions removed by differential 
ammonium sulfate precipitation from horse anti-
dog-lymphocyte serum. Note the marked hetero-
geneity of the fraction T. The two fractions were 
tested for their ability to mitigate renal homo-
graft rejection. 
antidog-Iymphocyte serum and the Fraction 
T removed from it caused prompt lympho-
penia with declines of the peripheral lym-
phocyte counts in dogs to 1,500 mm. 3 or 
less. There was a delayed lymphopenia with 
the administration of Fraction G but to a 
lesser degree and only after 10 days of con-
tinuous treatment. 
The results of canine renal homotrans-
plantation between nonrelated mongrel 
donors and recipients are shown in Table 
II. Of the 43 transplantations performed, 
six were eliminated from the analysis be-
cause of technical accidents which spoiled 
the experiments . 
The dogs treated with ALS and the Frac-
tions G and T had a significantly longer 
survival than the animals given no therapy. 
There seemed to be no difference when 
ALS and Fraction T (p > 0.1) were used, 
whereas the animals injected with Fraction 
G lived for somewhat shorter periods (p < 
0.01) . 
DISCUSSION 
The two animals that have been most com-
monly used as sources for ALS have been 
the rabbit and the horse. In the immunized 
rabbit, there has been little doubt that the 
antiwhite cell antibodies and the immuno-
suppressive effect reside in the gamma-G 
globulin.9 , 12-14, 20 The findings in the pres-
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Table II. Results of canine renal transplantation with whole horse ALS or globulin fractions being 
Protein concentration (Gm. %) Antibodies 
I I Beta" alpha, I 
Leukoag-
I 
Lympho-
Gamma T-equine and albumin Total glutinin cytotoxin 
Absorbed ALS 1.7 1.6 3.8 7.1 1: 2,048 1:512 
Fraction G 1.9 0.7 0.4 3.0 1:512 1: 512 
Fraction T 0.7 1.6 
No treatment 
2.6 4.9 1: 2,048 1: 256 
*By concentration or dilution, it was attempted to give the Frac don G injections the same gamma globulin contcnt as that in the 
the Fraction T \\-i<:h extraneous protein. 
ent study were in agreement with these 
earlier investigations in that both the leuko-
agglutinins and lymphocytotoxins of the 
rabbit serum were in the IgG. Moreover, 
essentially all the undesirable thromboag-
glutinins and the preponderance of the 
hemagglutinins were in the same location; 
some hemagglutinin activity also appeared 
to be in the IgM. The analysis of goat ALS 
provided almost identical results except 
that the hemagglutinins were exclusively 
found in the IgM. 
In the horse, a greater spread of the var-
ious antibodies has been reported by several 
authors during the first few months after 
beginning immunization.2, 8, 9, 16, 19 Most 
of these publications contained data indi-
cating that leukoagglutinins or cytotoxins or 
both were present not only in the IgG 
("slow" gamma G) but also in the T-equine 
globulin of which the principal constituent 
is IgA or "fast" gamma G; the skin graft 
experiments of James and Medawar9 sug-
gested that a Sephadex-separated 7S glob-
ulin that may have contained IgA was im-
munosuppressive. At a later time, after 3 to 
11 months of immunization, Pichlmayer and 
associates16 showed a shift of the antiwhite 
cell antibodies to the IgM fraction. 
The three horses in the present study 
which had received splenic cells for 6 to 9 
weeks were considered to be early serum 
donors. Essentially no leukoagglutinins or 
lymphocytotoxins were in the IgM. How-
ever, abundant antibodies were present in 
the T-equine globulin and, in fact, most of 
the leukoagglutinins were in this location 
whereas the lymphocytotoxins were primar-
ily in the IgG. The patterns of localization 
and the separability of these two kinds of 
activity were similar to the findings de-
scribed by Carraz and co-workers.2 
If, as appears to be the case, there are 
two distinct kinds of antiwhite cell antibodies 
in horse ALS, both apparently have immu-
nosuppressive qualities as judged by the 
canine kidney transplantation experiments 
that were done using the ALG prepared by 
differential ammonium sulfate preCIpIta-
tion. The IgA-rich Fraction T which con-
tained high leukoagglutinin but relatively 
low lymphocytotoxin titers was at least as 
effective as the IgG-rich Fraction G which 
had a greater lymphocytotoxicity relative to 
its leukoagglutinating properties. 
The results of these studies have not weak-
ened the generally held proposition that most 
of the active portion of equine ALS in the 
first months after the beginning of immuni-
zation is 7S gamma globulin. However, they 
do provide a possible explanation for the loss 
of potency seen with highly refined horse 
IgG since this fraction ("slow" gamma G) 
represents only part of the total activity. The 
other portion consists of the "fast" gamma 
G (IgA) , so called because of its slightly 
greater electrophoretic mobility. The IgA, 
which is buried in the T-equine globulin, 
is discarded in the process of refinement of 
IgG. Separation of the IgA from the other 
components of the heterogenous T-equine 
globulin and retention of it with the more 
easily removable IgG is a practical problem 
which has not yet been satisfactorily solved 
for mass production. 
Such difficulties can be avoided in a num-
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used* 
Hemag-
I 
Thrombo-
glutinin agglutinin 
1: 128 1:32 
1:128 1: 16 
1: 128 1 :32 
No. 
dogs Mean 
6 20.6 
10 16.3 
10 19.4 
11 9.9 
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Survival P value 
I Range I S.E.(I) To control I To ALS 
10-50 7.5 <0.01 
9-34 3.3 <0.01 <0.01 
11-35 3.3 <0.01 >0.1 
5-21 3.5 
ALS doses. A similar adjustment was made for the T-equine content of the Fraction T. Note the high degree of contamination of 
ber of other species. For example, the de-
sired immunoglobulins in both the rabbit 
and goat are in the IgG and in a condensed 
and relatively isolated segment of the se-
rum, thereby greatly simplifying the method-
ology for their nearly complete removal in 
an unadulterated form. The main disadvan-
tage is that large amounts of ALS cannot be 
so easily raised because of the limiting factor 
of low blood volume in small serum donors. 
SUMMARY 
The localization of antibodies was studied 
in rabbit, goat, and horse ALS raised by 
weekly immunization with canine or human 
spleen cells for 4 to 12 weeks. A combina-
tion of analytic techniques was used includ-
ing column chromatography, electrophoresis, 
immunoelectrophoresis, determination of 
protein concentration, and measurement of 
antibody titers. 
In the rabbit and goat ALS, virtually all 
of the leukoagglutinins and lymphocyto-
toxins were in the easily separable IgG; ac-
cidentally induced thromboagglutinins were 
in the same location. In the rabbit hemag-
glutinins were found in both the IgG and 
IgM, whereas in the goat these were almost 
exclusively in the IgM. 
The antiwhite cell antibodies were most 
widely distributed in the horse. The cyto-
toxins were primarily in the IgG, but the 
leukoagglutinins were most heavily concen-
trated in the T-equine globulin which con-
sists mostly of IgA. By differential ammo-
nium sulfate precipitation of a horse antidog-
lymphocyte serum, fractions were prepared 
that were rich in IgG and IgA. Both were 
able to delay the rejection of canine renal 
homografts, the IgA-rich preparation to a 
somewhat greater degree. The findings in 
this study have been discussed in relation to 
the refining techniques that have been used 
for the production of globulin from heterol-
ogous ALS. 
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